Abridge Partners With Nvidia and Eli Lilly to Build Clinical‑Conversation AI
The agreements back a Nemotron‑based foundation model fine‑tuned on Abridge’s de‑identified clinical audio and aim to expand the company’s platform into documentation, billing, and trial‑screening workflows later this year.
